About UsJay Michael S Balagtas, M.D. 
Clinical/Research Interests
Clinical Interests: Dr. Balagtas specializes in the diagnosis and treatment of pediatric cancers and blood disorders. As the Principal Investigator of the Children's Oncology Group (COG) for UC Davis Medical Center, he oversees all the therapeutic pediatric cancer clinical trials available through the UC Davis Cancer Center.
Research Interests: Particular research interests include the genetic changes underlying pediatric cancer and translation of these discoveries into effective clinical therapy.
Title:
Specialty:
Center/Program Affiliation:
Address:
2521 Stockton Blvd., Suite 3300
Sacramento, CA 95817
Education:
Valhalla, New York
M.D. 1998
UC San Diego
La Jolla, California
B.S. 1994
Internships:
San Diego, CA
1998-99
Residency:
San Diego, CA
2001-03
Pediatrics
Fellowships:
Palo Alto, CA
2007-09
Pediatric Hematology/Oncology
Lucile Packard Children’s Hospital,Stanford University (Clinical Fellow)
Palo Alto, CA
2006-07
Pediatric Hematology/Oncology
Board Certifications:
American Board of Pediatrics, 2003
Professional Memberships:
American Society of Hematology
Children’s Oncology Group
Honors and Awards:
Harry Lyon Machen Research Fellow, 2009
Susan and Lynn Orr LPCH Clinical Fellow in Hematology/Oncology, 2006
Letter of Appreciation, Commanding Officer, US Naval Hospital, Guam, 2004
Navy/Marine Corps Commendation Medal, 2001
Navy/Marine Corps Achievement Medal, 2000
Designated Surface Warfare Medical Department Officer, 2000
Matthew P. Hagadus, M.D. Good Physician Award, 1998
Merck Manual Academic Achievement Award, 1998
Cor et Manus Community Service Award, 1998
Alpha Omega Alpha Honor Medical Society, 1997
Select Recent Publications:
Balagtas JM, Dahl GV. Therapeutic complications in a patient with high-risk acute lymphoblastic leukemia and undiagnosed hereditary hemochromatosis. Pediatr Blood Cancer. 2012 Jan;58(1):101-3. doi: 10.1002/pbc.22829.
Sutherland SM, Hong DK, Balagtas J, Gutierrez K, Dvorak CC, Sarwal M. Liposomal amphotericin B associated with severe hyperphosphatemia. Pediatr Infect Dis J. 2008 Jan;27(1):77-9.